Novo Nordisk | NVO - 流动资产

金融业

DKK

DKK 76.18B

现金及等价物

DKK 38.94B

DKK 1.95B

DKK 25.71B

DKK 32.79B

DKK 118.72B

股息收益率

DKK 3.11

DKK 5.18B

DKK 31.44B

DKK 54.39K

EPS每股收益

DKK 1.02

股本和储备

DKK 26.56B

DKK 64.01B

债务利息支出

DKK 82.1M

DKK 3.43B

DKK 14.02B

DKK 157.42B

DKK 4.03B

DKK 6.5B

DKK 5.18B

普通股股本

DKK 4.44B

13.93

DKK 25.52B

DKK 12.53B

销售和管理费用

DKK 2.86B

DKK 42.85B

贸易债权人

DKK 4.46B

应收帐款人

DKK 14.27B

	流动资产	更改		日
ANI Pharmaceuticals	USD 747.08M		6.03M	2026-03
Aurora Cannabis	CAD 445.84M		22M	2025-12
Bausch Health Companies	USD 5.98B		179M	2026-03
Bristol-Myers Squibb	USD 27.21B		2.18B	2026-03
Canopy Growth	CAD 524.67M		78.85M	2025-12
Corcept Therapeutics	USD 426.03M		59.43M	2026-03
Drreddys Laboratories	INR 3.31B		164.26M	2025-12
Eli Lilly	USD 54.84B		794M	2026-03
GlaxoSmithKline	GBP 17.76B		251M	2026-03
Merck	USD 35.02B		8.5B	2026-03
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Novartis	USD 26.61B		3.85B	2026-03
Novo Nordisk	DKK 177.32B		4.86B	2026-03
Novo Nordisk	DKK 25.71B		148.69B	2025-06
Pacira	USD 514.96M		33.01M	2026-03
Perrigo	USD 2.71B		85M	2026-03
Phibro Animal Health	USD 894.07M		31.88M	2026-03
Prestige Brands	USD 433.43M		63.98M	2025-12
Sanofi	EUR 30.16B		789M	2026-03
Supernus Pharmaceuticals	USD 731.58M		87.4M	2026-03
Zoetis	USD 6.47B		294M	2026-03